Annual CFF
$191.48 M
+$157.23 M+459.11%
December 31, 2021
Summary
- As of February 10, 2025, GMTX annual cash flow from financing activities is $191.48 million, with the most recent change of +$157.23 million (+459.11%) on December 31, 2021.
- During the last 3 years, GMTX annual CFF has risen by +$157.23 million (+459.11%).
Performance
GMTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$2.91 M
-$1.68 M-136.67%
September 30, 2022
Summary
- As of February 10, 2025, GMTX quarterly cash flow from financing activities is -$2.91 million, with the most recent change of -$1.68 million (-136.67%) on September 30, 2022.
- Over the past year, GMTX quarterly CFF has dropped by -$1.66 million (-132.88%).
Performance
GMTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
-$6.54 M
-$1.66 M-34.01%
September 30, 2022
Summary
- As of February 10, 2025, GMTX TTM cash flow from financing activities is -$6.54 million, with the most recent change of -$1.66 million (-34.01%) on September 30, 2022.
- Over the past year, GMTX TTM CFF has dropped by -$199.34 million (-103.39%).
Performance
GMTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GMTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +459.1% | -132.9% | -103.4% |
| 3 y3 years | +459.1% | -114.5% | -132.6% |
| 5 y5 years | +459.1% | -114.5% | -132.6% |
GMTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +146.9% | at low | -103.4% | at low |
| 5 y | 5-year | at high | -82.1% | -101.5% | at low | -103.1% | at low |
| alltime | all time | at high | -82.1% | -101.5% | at low | -103.1% | at low |
Gemini Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$2.91 M(+136.7%) | -$6.54 M(+34.0%) |
| Jun 2022 | - | -$1.23 M(+0.4%) | -$4.88 M(-6.7%) |
| Mar 2022 | - | -$1.23 M(+3.9%) | -$5.24 M(-102.7%) |
| Dec 2021 | $191.48 M | -$1.18 M(-5.7%) | $191.48 M(-0.7%) |
| Sep 2021 | - | -$1.25 M(-20.9%) | $192.80 M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$1.58 M(-100.8%) | $208.05 M(-0.8%) |
| Mar 2021 | - | $195.49 M(>+9900.0%) | $209.64 M(+512.1%) |
| Dec 2020 | $34.25 M | $141.00 K(-99.0%) | $34.25 M(+0.4%) |
| Sep 2020 | - | $14.00 M(>+9900.0%) | $34.11 M(+69.7%) |
| Jun 2020 | - | $9000.00(-100.0%) | $20.10 M(+0.0%) |
| Mar 2020 | - | $20.09 M | $20.09 M |
FAQ
- What is Gemini Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Gemini Therapeutics?
- What is Gemini Therapeutics annual CFF year-on-year change?
- What is Gemini Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Gemini Therapeutics?
- What is Gemini Therapeutics quarterly CFF year-on-year change?
- What is Gemini Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Gemini Therapeutics?
- What is Gemini Therapeutics TTM CFF year-on-year change?
What is Gemini Therapeutics annual cash flow from financing activities?
The current annual CFF of GMTX is $191.48 M
What is the all time high annual CFF for Gemini Therapeutics?
Gemini Therapeutics all-time high annual cash flow from financing activities is $191.48 M
What is Gemini Therapeutics annual CFF year-on-year change?
Over the past year, GMTX annual cash flow from financing activities has changed by +$157.23 M (+459.11%)
What is Gemini Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of GMTX is -$2.91 M
What is the all time high quarterly CFF for Gemini Therapeutics?
Gemini Therapeutics all-time high quarterly cash flow from financing activities is $195.49 M
What is Gemini Therapeutics quarterly CFF year-on-year change?
Over the past year, GMTX quarterly cash flow from financing activities has changed by -$1.66 M (-132.88%)
What is Gemini Therapeutics TTM cash flow from financing activities?
The current TTM CFF of GMTX is -$6.54 M
What is the all time high TTM CFF for Gemini Therapeutics?
Gemini Therapeutics all-time high TTM cash flow from financing activities is $209.64 M
What is Gemini Therapeutics TTM CFF year-on-year change?
Over the past year, GMTX TTM cash flow from financing activities has changed by -$199.34 M (-103.39%)